Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02197845 · ClinicalTrials.gov registry record · NA
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 353
- Enrollment target
NCT02197845 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 353 participants.
The verdict
NCT02197845, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 353 participants
- Enrollment target
Study Summary
Multi-phase, patient navigator-based program in the Richmond and Tidewater regions of Virginia to demonstrate: 1. the feasibility of using patient navigators to improve the percentage of children and adult (age 15 and older) patients with sickle cell disease (SCD) in SCD specialty care 2. the efficacy of using patient navigators to improve hydroxyurea (HU) (re-)initiation and adherence among adult patients with SCD eligible for HU (Patient navigators may also be known as public health workers.)
Interventions
- BEHAVIORAL Patient Navigator
- BEHAVIORAL Recruitment into Specialty Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02197845
The ClinicalTrials.gov registry entry for NCT02197845 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 353 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Patient Navigator is the first listed.
NCT02197845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02197845 about?
NCT02197845 is a clinical study titled "Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators". Multi-phase, patient navigator-based program in the Richmond and Tidewater regions of Virginia to demonstrate: 1. the feasibility of using patient navigators to improve the percentage of children and adult (age 15 and older) patients with sickle cell disease (SCD) in SCD specialty care 2. the effic...
What is the current status of trial NCT02197845?
This trial is currently completed. It is a NA study. The enrollment target is 353 participants. The study started on 2012-10. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT02197845?
The interventions under investigation include: Patient Navigator (BEHAVIORAL), Recruitment into Specialty Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT02197845?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.